Back to search

France· FR:64378030

CERETEC 500 microgrammes, trousse radiopharmaceutique

A medicinal product containing examétazime, registered in France by GE HEALTHCARE.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCERETEC 500 microgrammes, trousse rad…ATC—REGISTER NO.FR:64378030PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
EXAMÉTAZIME
Manufacturer
GE HEALTHCARE
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955617952
    5 flacon(s) en verre de 5 mg

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Examétazime in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All examétazime products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Medi-Exametazim
  • Belgium · Exametazime Radiopharmacy Laboratory, Stabilised Ceretec
  • Czechia · Brain - Spect Kit, Exametazim Radiopharmacy Laboratorium
  • Germany · Medi-Exametazim
  • Denmark · Ceretec, Medi-Exametazim
  • Spain · Ceretec, Ceretec Estabilizado
  • Finland · Ceretec
  • United Kingdom (Northern Ireland) · Ceretec, Stabilised Ceretec
  • Greece · Ceretec
  • Hungary · Brain-Spect, Ceretec
  • Italy · Ceretec, Exametascan
  • Lithuania · Ceretec
  • Luxembourg · Medi-Exametazim, Stabilised Ceretec
  • Netherlands · Ceretec, Exametazime Radiopharmacy Laboratory
  • Norway · Ceretec, Exametazime Radiopharmacy Laboratory
  • Portugal · Exametazima Radiopharmacy
  • Sweden · Ceretec Stabilised, Exametazim Radiopharmacy Laboratory
  • Slovenia · Eksametazim Radiopharmacy Laboratory
  • Slovakia · Ceretec

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee8cf89a-635f-4eaf-9f86-9e05762471cb
GET /v1/drugs/ee8cf89a-635f-4eaf-9f86-9e05762471cb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64378030",
  "date_amm": "1987-12-07",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "EXAMÉTAZIME",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "trousse radiopharmaceutique",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about examétazime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.